title: Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers.
abstract: Genes have been identified for which germline mutations are associated with high lifetime risks of breast, colorectal and other cancers. Identification of mutation carriers through genetic testing is important as it could help lower cancer incidence and mortality. The translation of genetic information into better health outcomes is expensive because of the costs of genetic counselling as well as laboratory testing. Approaches to triage for mutation screening of known genes which rely on cancer family history are not necessarily sensitive and specific or the most cost-effective. Recent population-based research has shown that the cancers and precancerous lesions arising in mutation carriers have specific molecular and morphological characteristics. People with colorectal cancer, especially those diagnosed at a young age, whose tumours exhibit microsatellite instability and some specific pathology and immunohistochemically-defined features are more likely to carry a germline mutation in one of four mismatch repair genes. Some morphological and immunohistochemically-defined features are associated with breast cancers arising in women who carry BRCA1 or BRCA2 germline mutations, especially if at a young age. Screening paradigms based on molecular and morphological features that predict mutation status, especially if focused on early-onset disease, have the potential to identify mutation carriers with greater sensitivity and specificity, and in a more cost-effective way, than those based on family history alone. Genetic testing results could help inform treatment if those affected are tested soon after diagnosis using pathology-led selection strategies to identify cases most likely to carry germline mutations. We propose how this new approach could be undertaken by having genetic testing and counselling prioritised to those with the greatest probability of carrying a germline mutation in these known cancer predisposition genes.
authors.affiliation: The University of Melbourne, School of Population Health, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Carlton, Australia. j.hopper@unimelb.edu.au
authors.forename: J L
authors.initials: JL
authors.lastname: Hopper
authors.forename: M A
authors.initials: MA
authors.lastname: Jenkins
authors.forename: J G
authors.initials: JG
authors.lastname: Dowty
authors.forename: G S
authors.initials: GS
authors.lastname: Dite
authors.forename: C
authors.initials: C
authors.lastname: Apicella
authors.forename: L
authors.initials: L
authors.lastname: Keogh
authors.forename: A K
authors.initials: AK
authors.lastname: Win
authors.forename: J P
authors.initials: JP
authors.lastname: Young
authors.forename: D
authors.initials: D
authors.lastname: Buchanan
authors.forename: M D
authors.initials: MD
authors.lastname: Walsh
authors.forename: C
authors.initials: C
authors.lastname: Rosty
authors.forename: L
authors.initials: L
authors.lastname: Baglietto
authors.forename: G
authors.initials: G
authors.lastname: Severi
authors.forename: K A
authors.initials: KA
authors.lastname: Phillips
authors.forename: E M
authors.initials: EM
authors.lastname: Wong
authors.forename: A
authors.initials: A
authors.lastname: Dobrovic
authors.forename: P
authors.initials: P
authors.lastname: Waring
authors.forename: I
authors.initials: I
authors.lastname: Winship
authors.forename: S J
authors.initials: SJ
authors.lastname: Ramus
authors.forename: G G
authors.initials: GG
authors.lastname: Giles
authors.forename: M C
authors.initials: MC
authors.lastname: Southey
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology*; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000473:pathology*; D005260:Female; D020022:Genetic Predisposition to Disease; D018095:Germ-Line Mutation; D006801:Humans; D008297:Male